We believe the next decade will be transformational for healthcare and life sciences.
Advances in computing, technology, and biology are compounding at a dizzying pace. The case for change has never been clearer, yet healthcare remains one of the least digitized sectors of the economy.
We get excited about founders who are laying the foundation for a more connected and data-driven ecosystem. Those enabling a future that is more personalized, preventative, and predictive.
If you’re working on core healthcare or life sciences infrastructure or solutions that can dramatically move the needle on access, costs, or outcomes in areas such as home health, back office automation, clinical trials tech, AI-enabled R&D, pharma and provider software tools, let’s talk!
We have one of the largest and most exciting digital health & TechBio portfolios in Europe. We back bold, visionary founders at the earliest stages of their journey and aspire to be your first call.
We have built and scaled health & bio startups, practiced medicine, and studied physics, biology & engineering. We get what you do, the “chaos” of the earliest stages, and are obsessed with helping you build, scale, and succeed.
From our advisors to VCs, experienced founders, providers, payors, and pharma, we connect you with the people you need to succeed. If we don’t have a connection yet, we will hustle with you to find it.
VCs invested $1 billion in early-stage femtech in 2022. Speedinvest's Daria Gherghelas and Estelle Botbol untangle the data and introduce 440-plus femtech startups.
Speedinvest's Estelle Botbol explains what non-dilutive funding is and shares non-dilutive funding options for startups from all across Europe.
Discover more articles like these on the Speedinvest Blog